Published in Fertil Steril on June 01, 2002
Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 1.44
miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance. Diabetes (2013) 1.17
Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev (2012) 1.05
Assessing and treating insulin resistance in women with polycystic ovarian syndrome. World J Diabetes (2011) 1.02
Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome. Hum Reprod (2011) 0.92
Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome. J Clin Endocrinol Metab (2012) 0.92
Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Polycystic Ovary Syndrome. Int J Endocrinol (2012) 0.89
Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis. J Clin Endocrinol Metab (2013) 0.85
Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome. J Womens Health (Larchmt) (2010) 0.84
Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}. J Clin Endocrinol Metab (2010) 0.83
Association of Gly972Arg variant of insulin receptor subtrate-1 and Gly1057Asp variant of insulin receptor subtrate-2 with polycystic ovary syndrome in the Chinese population. J Ovarian Res (2014) 0.83
TNF-α haplotype association with polycystic ovary syndrome - a South Indian study. J Assist Reprod Genet (2013) 0.83
Glucose-stimulated oxidative stress in mononuclear cells is related to pancreatic β-cell dysfunction in polycystic ovary syndrome. J Clin Endocrinol Metab (2013) 0.81
The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma. PPAR Res (2007) 0.80
Do ACE I/D gene polymorphism serve as a predictive marker for age at onset in PCOS? J Assist Reprod Genet (2012) 0.80
Polycystic ovary syndrome is associated with an increased prevalence of irritable bowel syndrome. Dig Dis Sci (2009) 0.79
Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis. Sci Rep (2015) 0.78
The expression of the miR-25/93/106b family of micro-RNAs in the adipose tissue of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2014) 0.77
Is insulin resistance an intrinsic defect in asian polycystic ovary syndrome? Yonsei Med J (2013) 0.77
Current trends in the treatment of polycystic ovary syndrome with desire for children. Ther Clin Risk Manag (2009) 0.77
Pancreatic β-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-κB activation and systemic inflammation. Am J Physiol Endocrinol Metab (2015) 0.77
Cardiometabolic health among gastric bypass surgery patients with polycystic ovarian syndrome. World J Diabetes (2013) 0.77
Estradiol Binds to Insulin and Insulin Receptor Decreasing Insulin Binding in vitro. Front Endocrinol (Lausanne) (2014) 0.77
Insulin resistance and fertility in polycystic ovary syndrome. J Med Life (2010) 0.77
Correlation of Serum Lipoprotein Ratios with Insulin Resistance in Infertile Women with Polycystic Ovarian Syndrome: A Case Control Study. Int J Fertil Steril (2016) 0.77
Does polycystic ovary syndrome itself have additional effect on apelin levels? Obstet Gynecol Int (2014) 0.75
Prevalence and clinical profile of insulin resistance in young women of poly cystic ovary syndrome: A study from Pakistan. Pak J Med Sci (2013) 0.75
Lack of Association of Vitamin D Receptor FokI (rs10735810) (C/T) and BsmI (rs1544410) (A/G) Genetic Variations with Polycystic Ovary Syndrome Risk: a Case-control Study from Iranian Azeri Turkish Women. Maedica (Buchar) (2012) 0.75
Progesterone levels on the hCG day and outcomes in vitro fertilization in women with polycystic ovary syndrome. J Assist Reprod Genet (2012) 0.75
Indexes of Insulin Resistance in Hyperinsulinemic Polycystic Ovary Syndrome in a Macedonian Cohort of Women of Reproductive Age: A Cross-Sectional Study. Open Access Maced J Med Sci (2016) 0.75
Evaluation of early atherosclerotic findings in women with polycystic ovary syndrome. J Ovarian Res (2011) 0.75
Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome. Yonsei Med J (2016) 0.75
Does endothelial dysfunction correlate with endocrinal abnormalities in patients with polycystic ovary syndrome? Avicenna J Med (2016) 0.75
A new perspective in diagnosing polycystic ovary syndrome. J Natl Med Assoc (2007) 0.75
Leptin levels in relation to marital status and neuroendocrine function in Iraqi females with polycystic ovary syndrome. Saudi Pharm J (2009) 0.75
Association study of polymorphism of FXIIIVal34Leu gene and polycystic ovary syndrome. Int J Clin Exp Med (2014) 0.75
Female Gender Scheme is Disturbed by Polycystic Ovary Syndrome: A Qualitative Study From Iran. Iran Red Crescent Med J (2014) 0.75
Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review. Fertil Res Pract (2016) 0.75
Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome. J Res Med Sci (2017) 0.75
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 3.80
Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab (2006) 3.46
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol (2011) 3.02
Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 2.28
Retracted Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab (2008) 2.21
Use of metformin in polycystic ovary syndrome. Am J Obstet Gynecol (2008) 1.92
Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril (2005) 1.82
Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab (2006) 1.56
Laparoscopic evaluation following failure to achieve pregnancy after ovulation induction with clomiphene citrate. Fertil Steril (2003) 1.51
Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet (2011) 1.51
The severity of menstrual dysfunction as a predictor of insulin resistance in PCOS. J Clin Endocrinol Metab (2013) 1.50
Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome. Fertil Steril (2008) 1.49
Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 1.44
Reproductive hormone exposure timing and ischemic heart disease: Complicated answers to a simple question. Maturitas (2010) 1.39
Fifteen-year trend in the use of male reproductive surgery: analysis of the healthcare cost and utilization project data. BJU Int (2011) 1.39
Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril (2005) 1.34
Socioeconomic and racial predictors of undergoing laparoscopic hysterectomy for selected benign diseases: analysis of 341487 hysterectomies. J Minim Invasive Gynecol (2008) 1.33
Visually scoring hirsutism. Hum Reprod Update (2009) 1.21
Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women. J Clin Endocrinol Metab (2006) 1.19
Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated. J Clin Epidemiol (2004) 1.18
Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) (2005) 1.17
Nonclassic congenital adrenal hyperplasia. Int J Pediatr Endocrinol (2010) 1.17
miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance. Diabetes (2013) 1.17
FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. PLoS One (2011) 1.16
Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab (2006) 1.13
Novel pathway of adipogenesis through cross-talk between adipose tissue macrophages, adipose stem cells and adipocytes: evidence of cell plasticity. PLoS One (2011) 1.12
Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril (2009) 1.10
The adrenal and polycystic ovary syndrome. Rev Endocr Metab Disord (2007) 1.09
Diagnosis of polycystic ovary syndrome. Clin Obstet Gynecol (2007) 1.08
Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. J Clin Endocrinol Metab (2008) 1.06
Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2004) 1.06
From the eye of the nurses: 360-degree evaluation of residents. J Contin Educ Health Prof (2009) 1.04
Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertil Steril (2006) 1.03
Congenital adrenal hyperplasia. J Pediatr Adolesc Gynecol (2011) 1.03
Defining hirsutism in Chinese women: a cross-sectional study. Fertil Steril (2011) 1.01
Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation. Fertil Steril (2009) 1.01
Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. J Clin Endocrinol Metab (2013) 1.01
Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys. PLoS One (2011) 1.00
Difference in dietary intake between women with polycystic ovary syndrome and healthy controls. Fertil Steril (2006) 1.00
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). J Womens Health (Larchmt) (2009) 1.00
Reanalyzing the modified Ferriman-Gallwey score: is there a simpler method for assessing the extent of hirsutism? Fertil Steril (2011) 0.97
Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS. Fertil Steril (2008) 0.96
Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 0.96
Role of diet in the treatment of polycystic ovary syndrome. Fertil Steril (2006) 0.95
The age-associated decline of androgens in reproductive age and menopausal Black and White women. J Clin Endocrinol Metab (2007) 0.95
Nonreplication of the type 5 17beta-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 0.94
Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome. Fertil Steril (2011) 0.94
A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency. Int J Pediatr Endocrinol (2010) 0.94
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study. J Clin Endocrinol Metab (2005) 0.93
Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease. J Clin Endocrinol Metab (2008) 0.93
The Associations Between Residents' Behavior and the Thomas-Kilmann Conflict MODE Instrument. J Grad Med Educ (2010) 0.93
First evidence of genetic association between AKT2 and polycystic ovary syndrome. Diabetes Care (2008) 0.93
Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome. J Clin Endocrinol Metab (2012) 0.92
Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals. J Clin Endocrinol Metab (2015) 0.92
Laser hair reduction in the hirsute patient: a critical assessment. Hum Reprod Update (2002) 0.91
Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2009) 0.91
Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene. J Clin Endocrinol Metab (2009) 0.90
A pilot randomized, single-blind, placebo-controlled trial of traditional acupuncture for vasomotor symptoms and mechanistic pathways of menopause. Menopause (2012) 0.90
Diagnosing the diagnosis: why we must standardize the defining features of polycystic ovary syndrome. Ann Clin Biochem (2008) 0.89
DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE). J Clin Endocrinol Metab (2010) 0.89
Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOS. Clin Endocrinol (Oxf) (2013) 0.89
Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance. Fertil Steril (2005) 0.89
Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3. Fertil Steril (2008) 0.89
Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome. Fertil Steril (2006) 0.89
Preliminary evidence of glycogen synthase kinase 3 beta as a genetic determinant of polycystic ovary syndrome. Fertil Steril (2007) 0.88
Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis. Mol Hum Reprod (2012) 0.87
Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome. Fertil Steril (2011) 0.86
Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative. Int J Pediatr Endocrinol (2011) 0.86
Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters. Fertil Steril (2006) 0.86
Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome. Fertil Steril (2004) 0.86
Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess. Fertil Steril (2004) 0.86
The prevalence of androgen excess among patients with minimal unwanted hair growth. Am J Obstet Gynecol (2004) 0.84
Promoting residents' professional development and academic productivity using a structured faculty mentoring program. Teach Learn Med (2010) 0.83
Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome. J Clin Endocrinol Metab (2004) 0.83
Socioeconomic status and polycystic ovary syndrome. J Womens Health (Larchmt) (2011) 0.83
Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS). Steroids (2011) 0.83
Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling. J Clin Endocrinol Metab (2002) 0.83
Effect of oral estrogen on substrate utilization in postmenopausal women. Fertil Steril (2007) 0.83
Resistin stimulation of 17alpha-hydroxylase activity in ovarian theca cells in vitro: relevance to polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 0.83
Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}. J Clin Endocrinol Metab (2010) 0.83
Family size in women with polycystic ovary syndrome. Fertil Steril (2006) 0.82
Correlation of adrenocorticotropin steroid levels between women with polycystic ovary syndrome and their sisters. Am J Obstet Gynecol (2007) 0.82
Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone. J Clin Endocrinol Metab (2003) 0.82
The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: a report from the Los Angeles Atherosclerosis Study. J Clin Endocrinol Metab (2010) 0.81
Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome. Fertil Steril (2004) 0.81
Effect of insulin and testosterone on androgen production and transcription of SULT2A1 in the NCI-H295R adrenocortical cell line. Fertil Steril (2008) 0.81
Reproducibility of the adrenal androgen response to adrenocorticotropic hormone stimulation. Fertil Steril (2006) 0.81
Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome. Hum Reprod (2014) 0.81
Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2008) 0.80
Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility. J Clin Endocrinol Metab (2012) 0.80
The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia. Fertil Steril (2009) 0.80
Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in females. J Clin Endocrinol Metab (2013) 0.79
Polycystic ovary syndrome is associated with an increased prevalence of irritable bowel syndrome. Dig Dis Sci (2009) 0.79
Effect of oral micronized progesterone on androgen levels in women with polycystic ovary syndrome. Fertil Steril (2002) 0.79
Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome. Ther Clin Risk Manag (2008) 0.79
Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society. Fertil Steril (2009) 0.79
Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome. Fertil Steril (2009) 0.79
Polycystic ovary syndrome is a family affair. J Clin Endocrinol Metab (2008) 0.79
Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess. Fertil Steril (2005) 0.78
Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage. Mol Hum Reprod (2012) 0.78